Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Autologous Mesenchymal Stem Cells (LifeStem)
- Development stage
- Phase 4
- Lead developer
- LifeStem
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intraovarian
01
Overview
Autologous Mesenchymal Stem Cells is a regenerative cell therapy developed by LifeStem for the treatment of Premature Ovarian Failure (POF) in women. The therapy involves harvesting mesenchymal stem cells (MSCs) from the patient's own body, which are then processed and transplanted back into the ovaries, typically via laparoscopy-guided injection. The mechanism of action relies on the regenerative and immunomodulatory properties of MSCs, which are thought to repair damaged ovarian tissue and restore the ovarian niche by secreting paracrine factors such as growth factors and cytokines. This process aims to restore hormonal balance, promote follicular development, and potentially recover fertility in patients whose ovarian function has ceased prematurely.
- Other names
- Autologous MSCsAutologous Stem Cells
Beyond the preview
Go deeper on Autologous Mesenchymal Stem Cells (LifeStem).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Autologous Mesenchymal Stem Cells (LifeStem).